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alert and fully oriented. Neurological examination revealed 
right hemiparesis (grade 3/5). In the past medical history, he 
had undergone a craniotomy in the left fronto-parietal region 
for brain tumor 10 years ago in another hospital. Although we 
could not obtain pathological and medical records, he informed 
that his brain tumor had been diagnosed as low grade glioma, 
and he had received radiation therapy following craniotomy. 
Magnetic resonance images (MRI) and computed tomography 
(CT) scan on admission demonstrated a poorly defined heterog-
enously enhancing mass with extensive peritumoral edema in 
the left frontal motor cortex (Fig. 1). Since the mass was located 
near the previous craniotomy site, we suggested that this tumor 
might be related with previously diagnosed glioma. Under the 
presumptive diagnosis of secondary tumor, malignant transfor-
mation of a low grade glioma or radiation induced glioblasto-
ma, we performed the surgical resection of the tumor. The his-
topathological diagnosis was compatible with GBM (Fig. 2). 
After the operation, the patient made uneventful recovery and 
showed improvement of his right motor function. The MRI 
scans taken 2 weeks later showed a remnant mass in the left 
frontal lobe (Fig. 3). Considering his previous history of radia-
INTRODUCTION
Glioblastoma multiforme (GBM) is the most aggressive intra-
cranial tumor. GBM diffusely infiltrates the surrounding brain 
tissue, but does not typically invade blood vessels and rarely 
spreads outside the central nervous system (CNS). Metastasis to 
the outside of the CNS was accounted for in only 0.2% cases4). 
The most common site of extraneural metastasis of the GBM is 
pleura and the lung10,12). Although the exact mechanism of ex-
traneural metastasis has been poorly understood, the lymphatic 
drainage, the venous system and the adjacent dura and bone 
have been suggested as the three possible routes of extraneural 
spread2). Interestingly, we experienced a rare case of extraneural 
metastasis of the GBM, presenting as an unusual neck mass. 
Herein, we report this unusual case, with review of the literature, 
and we suggest the risk factors of extraneural metastasis.
CASE REPORT
A 46-year-old man was referred to our neurosurgical unit com-
plaining of progressive right hemiparesis. At admission, he was 
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temozolomide. Since then, he underwent craniotomy two more 
times and shunt procedure for the recurrence of the tumor and 
hydrocephalus for 30 months. Five years after the initial diagno-
sis, a palpable mass lesion was observed on his left side of the 
neck. The mass was firm, tender and associated with enlarged 
palpable cervical lymph node. The neck CT with contrast en-
hancement revealed a 3×4 cm sized round mass, with peripheral 
rim enhancement in the left side of the neck (Fig. 4B). Mass was 
biopsied and the histopathology indicated a metastatic deposit of 
the GBM. At that time, his condition, including consciousness 
and motor function, worsened, and the brain MRI noted the pro-
gression of the GBM. We performed the 
surgical resection of the brain tumor 
and of the neck mass, simultaneously. 
The pathological specimens were shown 
with increased cellularity, with blood 
vessel proliferation and necrosis (30%). 
The Ki-67 proliferation index was about 
50%. All pathological specimens, from 
both the brain tumor and the neck mass, 
were confirmed as GBM (Fig. 5). De-
spite the aggressive treatment for the 
GBM, the patient was aggravated and 
died 6 months later.
tion therapy, we performed gamma knife radiosurgery for the 
remnant mass, with a marginal dose of 20 Gy to the 50% isodose 
line, followed by 6 cycles of adjuvant chemotherapy with the 
PCV regimen (i.e. procarbazine, lomustine, and vincristine). Af-
ter the gamma knife radiosurgery, the patient was not followed 
up. Three years later, he presented with progressive weakness of 
the right extremities and dysarthria. The MRI showed a recur-
rent tumor in the left cerebral hemisphere (Fig. 4A). Surgical re-
section was done for the mass lesion and the histopathological 
findings revealed recurrence of the GBM. He remained in a sta-
ble condition during the 6 cycles of adjuvant chemotherapy with 
Fig. 1. Preoperative gadolinium enhanced T1-weighted magnetic resonance image (MRI) demon-
strates a mass lesion with peripheral irregular well enhancement in the left parietal region (A). 
Preoperative T2-weighted coronal MRI (B) and computed tomography scan (C) show bony defect 
(arrow) suggesting previous craniotomy near the mass lesion. 
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Fig. 2. Histologic findings after first operation show pleomorphic astro-
cytic tumor cells with mitosis and nuclear atypia (hematoxylin-eosin, 
original magnification, ×400). 
Fig. 5. Pathological specimen from the neck reveals increased cellulari-
ty, with blood vessel proliferation and necrosis (hematoxylin-eosin, origi-
nal magnification, ×400).
Fig. 3. Contrast enhanced magnetic resonance images taken 2 weeks 
after the first surgery shows remnant mass lesion in the parietal region.
Fig. 4. A : Three-year follow up contrast enhanced magnetic resonance 
image shows increased enhancing mass of the left parietal lobe. B : The 
neck CT scan with contrast enhancement reveals new peripheral en-
hancing lesion with lymph node enlargement in the left neck. CT : com-
puted tomography.
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(59.7%) lung and pleural, 37 (51.4%) lymph node, 22 (30.5%) 
bone, 16 (22.2%) liver, 5 heart, 3 adrenal gland, 2 each in the 
kidneys, diaphragm and mediastinum, and 1 each in the pan-
creas, the thyroid gland, and the peritoneum11).
For establishing the presence of extraneural metastasis, the 
following 4 criteria should be met16) : 1) the metastatic lesion 
must be histologically identified as CNS tumor; 2) the clinical 
history must indicate a CNS tumor as the initial neoplasm; 3) a 
complete autopsy must be performed to exclude the possibility 
of any other primary tumor; 4) the morphologic features of the 
primary lesion and of the metastatic lesion must be identical. In 
this case, the patient fulfilled these criteria. 
At presentation with extraneural metastasis, this patient devel-
oped enlargement of the cervical lymph node. Since the patient 
showed the lymphatic involvement of the GBM as extraneural 
metastasis, we considered that the main pathway of extraneural 
metastasis might be the lymphatic spread. However, we could 
not exclude the hematogenous spread. The possibility of hema-
togenous metastasis to the neck should be included, because the 
patient had undergone multiple craniotomies. 
Although it has been well known that surgery could be a risk 
factor for the extraneural metastasis of the GBM, surgery is not 
a prerequisite for the extraneural spread of the primary CNS 
tumor. Spontaneous metastases also have been reported in pa-
tients who had not experienced previous surgery6). Spontane-
ous spreading of the tumor was attributed to direct invasion in 
both the vascular and the lymphatic systems. 
In summary, this patient survived for 6 years after aggressive 
treatments including surgery for 5 times, radiotherapy and che-
motherapy. We suggest that the relatively longer lifespan of this 
patient might have affected the extraneural metastasis of the 
GBM. The damage of the cerebral vessels and of the BBB by re-
peated surgical manipulations could also accelerate the tumor 
penetration outside of the CNS.
CONCLUSION
Although the exact mechanism of the extraneural metastasis 
is not well understood, the GBM can metastasize to extraneural 
organs. Multiple craniotomies and longer survival period of the 
patient could be considered as risk factors of the extraneural 
metastasis. This present case provides proof for the possibility of 
extraneural metastasis of the GBM, especially in patients with 
longer survival. The neuro-oncologists should pay attention to 
the systematic survey for extraneural metastasis of the GBM.
References 
1. Bernstein JJ, Woodard CA : Glioblastoma cells do not intravasate into 
blood vessels. Neurosurgery 36 : 124-132; discussion 132, 1995
2. Cervio A, Piedimonte F, Salaberry J, Alcorta SC, Salvat J, Diez B, et al. : 
Bone metastases from secondary glioblastoma multiforme : a case re-
port. J Neurooncol 52 : 141-148, 2001
3. Giese A, Loo MA, Rief MD, Tran N, Berens ME : Substrates for astrocy-
toma invasion. Neurosurgery 37 : 294-301; discussion 301-302, 1995
DISCUSSION
Glioblastoma multiforme is one of the most malignant neo-
plasms in human beings and the most common primary tumor 
in the cerebral hemisphere. The incidence accounts for 2 to 3 cas-
es/100000 per year in both Europe and North America, and 
75% of the patients die within 18 months from diagnosis13). 
GBM commonly spreads by direct extension and infiltration 
into the adjacent brain tissue and along the white matter tract. 
Although the tumor is associated with a strong tendency for lo-
cal invasiveness, the metastatic spread of the GBM outside of 
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